FIELD: biochemistry.
SUBSTANCE: invention is related to an antibody or its antigen-binding fragment that binds to human nectin-4. A polynucleotide encoding said antibody; a vector and a cell containing said polynucleotide; a kit containing the specified antibody are also disclosed. A method for producing said antibody; a method for determining the expression of nectin-4 using said antibody; a method of assessing the susceptibility of an individual with a malignant disease to an antitumor therapeutic agent using said antibody are disclosed.
EFFECT: invention makes it possible to effectively assess the susceptibility of an individual with a malignant disease to an antitumor therapeutic agent.
30 cl, 12 ex, 23 tbl, 13 dwg
Title | Year | Author | Number |
---|---|---|---|
ANTI-LAG-3 ANTIBODIES | 2016 |
|
RU2760582C2 |
ANTIBODIES FOR TREATMENT OF HEPATITIS B INFECTION AND RELATED DISEASES | 2018 |
|
RU2765878C2 |
ANTIBODIES SPECIFIC TO HUMAN NECTIN-4 | 2019 |
|
RU2825839C2 |
ANTIBODIES TO S. AUREUS SURFACE DETERMINANTS | 2013 |
|
RU2698131C2 |
ANTIBODIES TO SURFACE DETERMINANTS OF S. AUREUS | 2013 |
|
RU2808018C2 |
C10orf54 ANTIBODIES AND USE THEREOF | 2015 |
|
RU2714232C2 |
ANTI-C10orf54 ANTIBODIES AND APPLICATIONS THEREOF | 2015 |
|
RU2819627C1 |
BINDING PROTEINS AND METHODS FOR USE THEREOF | 2015 |
|
RU2701434C2 |
LIBRARIES OF SYNTHETIC POLYPEPTIDES AND METHODS OF OBTAINING VERSIONS OF POLYPEPTIDES WITH NATURAL DIVERSITY | 2010 |
|
RU2562163C2 |
ANTI-CD112R ANTIBODY COMPOSITIONS AND RELATED METHODS | 2019 |
|
RU2819624C2 |
Authors
Dates
2023-10-13—Published
2018-06-04—Filed